CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 29  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0640
LYS 10.0198
GLU 20.0134
LEU 30.0212
ARG 40.0194
CYS 50.0156
GLN 60.0268
CYS 70.0228
ILE 80.0640
LYS 90.0520
THR 100.0252
TYR 110.0268
SER 120.0144
LYS 130.0142
PRO 140.0089
PHE 150.0188
HIS 160.0276
PRO 170.0109
LYS 180.0128
PHE 190.0176
ILE 200.0151
LYS 210.0255
GLU 220.0182
LEU 230.0091
ARG 240.0240
VAL 250.0237
ILE 260.0344
GLU 270.0474
SER 280.0343
GLY 290.0364
PRO 300.0465
HIS 310.0161
CYS 320.0170
ALA 330.0355
ASN 340.0282
THR 350.0190
GLU 360.0194
ILE 370.0102
ILE 380.0168
VAL 390.0113
LYS 400.0107
LEU 410.0167
SER 420.0300
ASP 430.0348
GLY 440.0169
ARG 450.0101
GLU 460.0112
LEU 470.0138
CYS 480.0158
LEU 490.0129
ASP 500.0202
PRO 510.0176
LYS 520.0343
GLU 530.0368
ASN 540.0463
TRP 550.0238
VAL 560.0128
GLN 570.0214
ARG 580.0243
VAL 590.0079
VAL 600.0095
GLU 610.0138
LYS 620.0114
PHE 630.0099
LEU 640.0106
LYS 650.0112
ARG 660.0034
ALA 670.0132
GLU 680.0177
ASN 690.0313

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.